Vera Therapeutics, Inc. SEC filings VERA
Vera Therapeutics, Inc. has 476 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 15, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Other events
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Other events
|
Jun 2, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Other events
|
Dec 10, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 26, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 3, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Oct 31, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 28, 2024 | Oct 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 2, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Other events
|
Jan 30, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 29, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
New debt
|
Dec 26, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 20, 2023 | Jun 17, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2023 | May 10, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Other events
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Other events
|
Feb 2, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 1, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 3, 2023 | Jan 3, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 9, 2022 | Sep 9, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2022 | May 24, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2022 | Mar 24, 2022 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Dec 17, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2021 | Dec 10, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2021 | Jul 14, 2021 |
| 8-K |
Current report
Results of operations
|
Jun 24, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 18, 2021 | May 18, 2021 |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VERA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1831828
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.